Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
24.97
-0.40 (-1.58%)
At close: Jul 23, 2026, 4:00 PM EDT
24.97
0.00 (0.00%)
After-hours: Jul 23, 2026, 7:34 PM EDT
Privia Health Group Revenue
Privia Health Group had revenue of $603.85M in the quarter ending March 31, 2026, with 25.78% growth. This brings the company's revenue in the last twelve months to $2.25B, up 24.72% year-over-year. In the year 2025, Privia Health Group had annual revenue of $2.12B with 22.26% growth.
Revenue (ttm)
$2.25B
Revenue Growth
+24.72%
P/S Ratio
1.40
Revenue / Employee
$1,832,457
Employees
1,226
Market Cap
3.15B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.12B | 386.45M | 22.26% |
| Dec 31, 2024 | 1.74B | 78.65M | 4.74% |
| Dec 31, 2023 | 1.66B | 301.08M | 22.19% |
| Dec 31, 2022 | 1.36B | 390.44M | 40.41% |
| Dec 31, 2021 | 966.22M | 149.15M | 18.25% |
| Dec 31, 2020 | 817.08M | 30.72M | 3.91% |
| Dec 31, 2019 | 786.36M | 128.75M | 19.58% |
| Dec 31, 2018 | 657.61M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.51B |
| Tempus AI | 1.36B |
| HealthEquity | 1.34B |
| Omnicell | 1.23B |
| Waystar Holding | 1.16B |
| Hinge Health | 646.34M |
| Doximity | 644.86M |
| 10x Genomics | 638.78M |
PRVA News
- 13 hours ago - Privia Health price target raised to $35 from $32 at Citi - TheFly
- 16 days ago - Privia Health to Report Second Quarter 2026 Results on Thursday, August 6 - GlobeNewsWire
- 2 months ago - Cross Keys Capital Advises Neurology Group of Bergen County in Its Partnership with Privia Health - GlobeNewsWire
- 2 months ago - Privia Health partners with NGBC to enter New Jersey - TheFly
- 2 months ago - Privia Health Enters New Jersey - GlobeNewsWire
- 2 months ago - Privia Health price target lowered to $24 from $25 at Barclays - TheFly
- 2 months ago - Privia Health price target lowered to $34 from $35 at Canaccord - TheFly
- 2 months ago - Privia Health Group Earnings Call Transcript: Q1 2026 - Transcripts